Alexandra Jacquet

1.7k total citations
18 papers, 193 citations indexed

About

Alexandra Jacquet is a scholar working on Immunology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Alexandra Jacquet has authored 18 papers receiving a total of 193 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Alexandra Jacquet's work include Immunotherapy and Immune Responses (5 papers), T-cell and B-cell Immunology (5 papers) and Immune Cell Function and Interaction (4 papers). Alexandra Jacquet is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), T-cell and B-cell Immunology (5 papers) and Immune Cell Function and Interaction (4 papers). Alexandra Jacquet collaborates with scholars based in France, United States and Mali. Alexandra Jacquet's co-authors include Olivier Lantz, Nathalie T. Joncker, Julie Helft, Virginie Prémel, Adrien Kissenpfennig, Bernard Malissen, Isabelle Grandjean, Polly Matzinger, Guillaume Dorothée and Philippe Mondon and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Alexandra Jacquet

16 papers receiving 187 citations

Peers

Countries citing papers authored by Alexandra Jacquet

Since Specialization

Citations

This map shows the geographic impact of Alexandra Jacquet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandra Jacquet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandra Jacquet more than expected).

Fields of papers citing papers by Alexandra Jacquet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandra Jacquet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandra Jacquet. The network helps show where Alexandra Jacquet may publish in the future.

Co-authorship network of co-authors of Alexandra Jacquet

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandra Jacquet. A scholar is included among the top collaborators of Alexandra Jacquet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandra Jacquet. Alexandra Jacquet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Coffee and tea consumption, patient‐reported, and clinical outcomes in a longitudinal study of patients with breast cancer 2022 ·Cancer ·Davide Soldato, Julie Havas, Tracy E. Crane, Daniele Presti, (unknown), (unknown), Barbara Pistilli, Élise Martin, Lucia Del Mastro, Anne‐Laure Martin, Alexandra Jacquet, Charles Coutant, Paul Cottu, (unknown), Florence Lerebours, Olivier Trédan, Laurence Vanlemmens, Fabrice André, Inês Vaz-Luís, Antonio Di Meglio	3
2	Impact of radiation therapy on fatigue at 1 year in breast cancer survivors in the prospective multicentre CANcer TOxicity cohort 2022 ·European Journal of Cancer ·(unknown), Antonio Di Meglio, (unknown), Alexandra Jacquet, Sibille Everhard, Youlia Kirova, Karine Peignaux, Philippe Guilbert, C. Charra-Brunaud, (unknown), (unknown), Dominique Pasquier, S. Racadot, C. Bourgier, Julien Geffrelot, (unknown), François Paris, (unknown), Inês Vaz-Luís, Sofía Rivera	1
3	Abstract P3-12-12: ATTITUDE: Understanding and reducing ATTrition in longiTUDinal studiEs of cancer survivors 2022 ·Cancer Research ·(unknown), Julie Havas, Daniele Presti, Davide Soldato, Élise Martin, Barbara Pistilli, Aurélie Bertaut, (unknown), (unknown), Anne‐Laure Martin, Sibille Everhard, Alexandra Jacquet, Gwenn Menvielle, Matteo Lambertini, Laurence Vanlemmens, Stefan Michiels, Fabrice André, Inês Vaz-Luís, Antonio Di Meglio	1
4	1273P Durvalumab (D) compared to maintenance chemotherapy (SoC) in patients (pts) with metastatic non-small cell lung cancer (NSCLC): Results from the randomized SAFIR02 LUNG-IMMUNO trial 2020 ·Annals of Oncology ·Fabrice Barlési, Maryam Karimi, Pascale Tomasini, Catherine Daniel, Judith Raimbourg, (unknown), (unknown), Julien Mazières, Olivier Molinier, Clarisse Audigier-Valette, Denis Moro‐Sibilot, Hugues Morel, (unknown), Ivan Bièche, Alicia Tran-Dien, Alexandra Jacquet, Julien Adam, J.C. Soria, Benjamin Besse	0
5	Abstract GS1-08: Genomic characterisation of metastatic breast cancer 2019 ·Cancer Research ·Fabrice André, Thomas Filleron, (unknown), François Bertucci, (unknown), Alexandra Jacquet, Salvatore Piscuoglio, (unknown), (unknown)	3
6	A. Goddeeris, The Old Babylonian Legal and Administrative Texts in the Hilprecht Collection Jena, Part 1: Texts, Seal Impressions, Studies, Part 2: Indexes, Bibliography, Plates , Texte und Materialen der Hilprecht Collection 10, Wiesbaden, 2016 2018 ·Alexandra Jacquet	1
7	Abstract PD8-12: Mutational processes, genome evolution and outcome in metastatic breast cancers 2018 ·Cancer Research ·Anne Patsouris, Thomas Filleron, Alexandra Jacquet, Amanda Gonçalves, (unknown), (unknown), (unknown), (unknown), Fabrice André	1
8	Modeling the Specific CD4+ T Cell Response against a Tumor Neoantigen 2015 ·The Journal of Immunology ·Héloïse Flament, Ruby Alonso, Virginie Prémel, Nathalie T. Joncker, Alexandra Jacquet, Suzy Scholl, Olivier Lantz	7
9	Combined glyco- and protein-Fc engineering simultaneously enhance cytotoxicity and half-life of a therapeutic antibody 2014 ·mAbs ·Céline Monnet, Sylvie Jorieux, (unknown), (unknown), Alexandra Jacquet, Nathalie Fournier, Fabien Crozet, Christophe de Romeuf, Khalil Bouayadi, (unknown), Christian K. Behrens, Philippe Mondon, Alexandre Fontayne	38
10	Preclinical Study of Ublituximab, a Glycoengineered Anti-Human CD20 Antibody, in Murine Models of Primary Cerebral and Intraocular B-Cell Lymphomas 2013 ·Investigative Ophthalmology & Visual Science ·(unknown), Sabrina Donnou, Hanane Ouakrim, Lucile Crozet, Jérémie Cosette, Alexandra Jacquet, (unknown), (unknown), (unknown), (unknown), Valérie Touitou, Cécile Daussy, Marie‐Christine Naud, Wolf H. Fridman, Catherine Sautès‐Fridman, (unknown), Sylvain Fisson	25
11	Abstract 2528: 3C23K: an anti-human Mullerian inhibiting substance type II receptor humanized monoclonal antibody for ovarian cancer targeted therapy 2012 ·Cancer Research ·Alexandra Jacquet, Nathalie Kersual, Véronique Garambois, Alexandre Fontayne, (unknown), Nathalie Fournier, Martine Pugnière, Alain Chavanieu, Christophe de Romeuf, Jean‐François Prost, (unknown), André Pèlegrin, Christine Gaucher, (unknown)	2
12	Ublituximab (TGTX-1101), a Novel, Third-Generation Anti-CD20 Antibody Demonstrates Enhanced Antitumor Activity Compared to Rituximab in Primary CNS and Intraocular Lymphoma Murine Models. 2012 ·Blood ·Sabrina Donnou, (unknown), Jérémie Cosette, Hanane Ouakrim, Lucile Crozet, Alexandra Jacquet, Wolf H. Fridman, Catherine Sautès‐Fridman, Peter Sportelli, (unknown), Sylvain Fisson	1
13	A novel treatment for ovarian cancer (OC): Anti-Müllerian inhibiting substance type II receptor (MISRII) humanized monoclonal antibody (mAb) 3C23K—Preclinical validation. 2012 ·Journal of Clinical Oncology ·Christine Gaucher, Alexandra Jacquet, Nathalie Kersual, Véronique Garambois, Alexandre Fontayne, Nathalie Fournier, Christophe de Romeuf, Diégo Tosi, Alain Sadoun, (unknown), Jean‐François Prost, (unknown), André Pèlegrin, (unknown)	1
14	Long Peptide Vaccination Can Lead to Lethality through CD4+ T Cell-Mediated Cytokine Storm 2010 ·The Journal of Immunology ·Hiroshi Kitamura, Christine Sedlik, Alexandra Jacquet, Bruno Zaragoza, Mathilde Dusséaux, Virginie Prémel, Xavier Sastre‐Garau, Olivier Lantz	20
15	The Dendritic Cell–like Functions of IFN-Producing Killer Dendritic Cells Reside in the CD11b+ Subset and Are Licensed by Tumor Cells 2009 ·Cancer Research ·Magali Terme, Grégoire Mignot, Evelyn Ullrich, Mathieu Bonmort, Véronique Minard-Colin, Alexandra Jacquet, Joachim L. Schultze, Guido Kroemer, Claude Leclerc, Nathalie Chaput, Laurence Zitvogel	23
16	Antigen-specific T-T interactions regulate CD4 T-cell expansion 2008 ·Blood ·Julie Helft, Alexandra Jacquet, Nathalie T. Joncker, Isabelle Grandjean, Guillaume Dorothée, Adrien Kissenpfennig, Bernard Malissen, Polly Matzinger, Olivier Lantz	54
17	Intratumor CD4 T-Cell Accumulation Requires Stronger Priming than for Expansion and Lymphokine Secretion 2006 ·Cancer Research ·Nathalie T. Joncker, Julie Helft, Alexandra Jacquet, Virginie Prémel, Olivier Lantz	11
18	[Analogy of the affinity between a B antigen, modified by leukemia in an A1B subject, and a partial B antigen induced by a Cis A1B chromosome]. 1968 ·PubMed ·C Salmon, Alexandra Jacquet, (unknown), Didier Salmon	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact